"10.1371_journal.pone.0062837","plos one","2013-05-14T00:00:00Z","√Ängel Argil√©s; Justyna Siwy; Flore Duranton; Nathalie Gayrard; Mohammed Dakna; Ulrika Lundin; Lourdes Osaba; Christian Delles; Georges Mourad; Klaus M Weinberger; Harald Mischak","RD N√©phrologie, Montpellier, France; N√©phrologie Dialyse St Guilhem, S√®te, France; Service de N√©phrologie, Dialyse P√©riton√©ale et Transplantation, Montpellier, France; Mosaiques Diagnostics & Therapeutics AG, Hannover, Germany; Charit√©-Universit√§tsmedizin Berlin, Berlin, Germany; Biocrates life sciences AG, Innsbruck, Austria; Progenika Biopharma, S.A., Derio, Vizcaya, Spain; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: AA HM KW. Performed the experiments: JS FD NG LO UL. Analyzed the data: FD MD JS AA HM. Wrote the paper: AA HM GM CD.","HM is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology for clinical application. JS and MD are employees of Mosaiques Diagnostics. Mosaiques Diagnostics has applied for patent protection for biomarkers contained in the CKD273 classifier. LO is employed by Progenika Biopharma SA. UL was an employee of Biocrates Life Sciences, and KW was an employee and is a shareholder and advisor of Biocrates Life Sciences, a company offering contract research services and kit products in the field of metabolomics. This does not alter the authors‚Äô adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","√Ängel Argil√©s","√A√",11,TRUE,3,5,5,4,FALSE,FALSE,TRUE,1,"1",TRUE
